Geode Capital Management
ABVX

Geode Capital Management’s Abivax ABVX Stock Holding History

Geode Capital Management’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.91M Buy
51,868
+556
+1% +$62.9K ﹤0.01% 2740
2026
Q1 		$5.71M Buy
51,312
+1,379
+3% +$163K ﹤0.01% 2671
2025
Q4 		$6.73M Buy
49,933
+20,081
+67% +$2.19M ﹤0.01% 2610
2025
Q3 		$2.53M Buy
29,852
+13,034
+78% +$799K ﹤0.01% 3100
2025
Q2 		$129K Buy
16,818
+69
+0.4% +$450 ﹤0.01% 4002
2025
Q1 		$105K Hold
16,749
– – ﹤0.01% 4018
2024
Q4 		$123K Buy
16,749
+1,177
+8% +$10.8K ﹤0.01% 4050
2024
Q3 		$179K Buy
15,572
+1,183
+8% +$14.2K ﹤0.01% 3939
2024
Q2 		$190K Hold
14,389
– – ﹤0.01% 3926
2024
Q1 		$206K Buy
+14,389
New +$186K ﹤0.01% 3934

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management's ABVX Position: Q2 2026 in Review

Geode Capital Management increased its Abivax (ABVX) stake by 1.1% in Q2 2026, buying an estimated $62.9K and bringing the position to 51,868 shares worth $6.91M. The position accounts for ﹤0.01% of the portfolio, ranked #2740.

Geode Capital Management first reported a position in ABVX in Q1 2024 and has held it in 10 quarters since. 302 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Geode Capital Management held 51,868 shares of Abivax worth $6.91M as of Q2 2026.
  • Geode Capital Management bought 556 Abivax shares in Q2 2026, an estimated $62.9K.
  • Abivax made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2740 holding.
  • Geode Capital Management first reported a position in Abivax in Q1 2024 and has held it in 10 quarters since.
  • 302 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.